Precision Advisors Expands Strategic Team to Meet Business Growth in Pharmaceutical and Life Sciences
March 9, 2015, New York – Precision Advisors (www.precisionadvisors.com), a Precision for Medicine company, which combines real-world market experience and thought leadership to provide insight, strategy, and recommendations to pharmaceutical and life sciences companies, today announced recent additions to the company’s extensive experience in real-world payer decision making and market access strategy. Joining the team are Rachelle Wan, Senior Vice President; Dominic Galante, Chief Medical Officer; and Stephen Carter, Vice President.
“The shift by healthcare providers, insurers, and employers to quality- or value-based payment models is a driving force behind our commitment to create a new type of advisory consulting service,” said Larry Blandford, PharmD, executive vice president and managing partner of Precision Advisors. “We’re thrilled to add Rachelle, Dominic, and Steve as we expand our distinguished team of thought leaders who have the real-world experience to evaluate and recommend strategies for life sciences companies in this changing competitive landscape.”
Precision Advisors is part of Precision for Medicine, a company formed in 2012 to support next-generation approaches to drug development and commercialization. Together with Precision for Value, it provides integrated services and infrastructure to support pharmaceutical and life science companies as they develop and commercialize new products in the age of precision medicine.
Ms. Rachelle Wan is responsible for leading the team of payer advisors, which represents more than 200 years of direct experience as payer decision makers. Ms. Wan brings nearly 20 years of experience in the biotechnology, specialty pharmacy, and pharmacy benefit management (PBM) industries. Prior to joining Precision Advisors, Ms. Wan was with Prime Therapeutics, where she held roles including Vice President of Specialty Pharmacy Solutions, where she was responsible for developing the specialty pharmacy organization, including strategy, physician sales, manufacturer relations, and data analytics, as well as Vice President of Trade Manufacturer Relations. Before her roles at Prime, Ms. Wan was with Amgen, and spent a decade with CVS/Caremark where her responsibilities included clinical program management, account management, marketing, sales, manufacturer contracting, and trade relationships.
Dr. Dominic Galante now serves as full-time Chief Medical Officer for Precision Advisors. In this role, Dr. Galante oversees the implications of payer medical policy across all practice areas within Precision and the ramifications of healthcare provider evolution on life science companies. Prior to joining Precision Advisors, Dr. Galante was Vice President of Medical Quality Management at MVP Health Care where he was responsible for quality initiatives including physician and facility performance monitoring, reporting, and improvement. He achieved these goals with innovative performance-driven contracting and care delivery models, such as pay-for-performance and risk-gain sharing reimbursement models, as well as supporting health exchange plan development. Under Dr. Galante’s leadership, MVP Health Care was one of the top-ranked commercial and Medicare health plans in the United States, involved with implementing and overseeing practice transformation for patient-centered medical homes with over 1000 physicians covering 100,000 lives, and supported the implementation of two regional ACO contracts.
Mr. Stephen Carter joins Precision Advisors to lead client engagements in support of market access strategy, pricing and contracting, and competitive analysis. Mr. Carter brings more than 18 years of experience in advising pharmaceutical, biotechnology, device, and nutritionals life science companies on product, portfolio, and corporate strategy issues. Before joining Precision, he served in senior roles at Campbell Alliance, Charles River Associates, and Symphony Health, where he led engagements in pricing and access strategy, competitive simulations, commercialization effectiveness and the impact of healthcare reform on managed markets strategy.
For complete bios of these individuals as well as all the experts in Precision Advisors, please visit www.pfmadvisors.com.
About Precision Advisors
Precision Advisors combines real-world market experience with thought leadership and industry expertise to provide insight, strategy, and advice to innovative life science companies. Headquartered in Cambridge, Massachusetts, Precision Advisors’ unrivaled team of expert advisors encompass all areas of the commercialization spectrum including strategy consulting, managed markets, health economics, clinical research, and analytics. Visit www.pfmadvisors.com to learn more about how the expertise of Precision Advisors can inform your success.
About Precision for Medicine
Precision for Medicine is a specialized company providing services and infrastructure to support life sciences companies as they develop new products in the age of precision medicine. Precision brings expertise, technology, and project execution to support innovative, patient-centric solutions from discovery through commercialization. The company is headquartered in Bethesda, MD. Visit www.precisionformedicine.com for more information.
# # #
Precision for Medicine Media Relations
212-686-2650, ext. 3027